The biliary glycoproteins (BGPs) represent a group of at least eight differentially spliced molecules belonging to the carcinoembryonic antigen (CEA) subgroup of the CEA family. These molecules are recognized by the CD66 monoclonal antibodies (MoAbs) and function as homotypic and heterotypic adhesion molecules. Recently, at least eight transmembrane BGP molecules, and possibly three BGP-soluble forms (generated by differential splicing of a single BGP gene), have been identified by cloning and polymerase chain reaction (PCR) analys e~. ' .~.~,~ The BGP molecules are members of the Ig superfamily" and carry an IgV-like N-terminal domain together with 0 to 3 IgC2 set domains, a 32-amino acid transmembrane region, and a cytoplasmic tail of variable length.'' The largest BGP molecule, BGPa, consists of a 108-amino acid N-terminal IgV-like domain, two 178-amino acid IgC2 set domains (A1 and B1 following the nomenclature agreed to in the XVIIth Meeting of the International Society for Oncodevelopmental Biology and Medicine," a 100-amino acid IgC2 set domain, the A2 domain. These are followed by the transmembrane region and a 71-amino acid cytoplasmic tail.* Isoforms derived by alternative splicing lack the third A2 domain (BGPb and BGPd) and/or have a shortened cytoplasmic tail of 9 amino acids (BGPc, BGPd, BGPx', and BGPz).**~,~ Recent studies show the existence of isoforms with the N-terminal domain only (BGPx and BGPx') or with the A2 domain of BGPa and c replaced by a 31-amino acid non-IgC2 set domain, Y2 or 2 2 (BGPy and BGPz, respectively)' (see Fig 1) . At the amino acid level, the N-terminal and the AIB 1 sequences of BGP exhibit more than 70% identity with other members of the carcinoembryonic antigen (CEA) subfamily, whereas the A2 domain shows only 45% id en tit^.',^ In contrast, the Y2 and 2 2 domains are specific for the BGP family, displaying significant homology at the nucleotide level with an inverted and truncated human 
eloid cells, whereas the promonocytic cell line, U937, appears to express only the BGPa splice variant. On the other hand, BGPx and x' appear to be restricted to transformed cells and have not been found in normal tissues. RNase protection experiments3 show that the BGPc splice variant occurs more abundantly in colonic than in myeloid cell lines.
The human and rodent BGPs are thought to function as adhesion molecules being involved in homotypic and heterotypic interaction^.^*'^"' C-CAM-105, the putative rat equivalent of human BGP, may also function as an ecto-ATPase." The role of the different BGP splice variants has not been determined. However, the A2, Y2, and 2 2 domains may mediate additional heterotypic adhesion functions,' such as those observed with inserted sequences in fibroblast growth factor receptor (FGFR)''3'' and neural cell adhesion molecule (N-CAM) splice variant^.'^." Several investigators have suggested that splicing of the cytoplasmic tails of the BGP molecules may affect both their ability to transduce signals and to became ph~sphorylated,'~~~'~~~'~~~~ and that each isoform may function differently according to differences in its extracellular and cytoplasmic domains.
A detailed understanding of the functions of the different splice variants and of the different domains expressed by these splice variants is required. In this report, we describe the use of a full-length clone of the BGPc isoform3 together with soluble recombinant domain variants of BGPc to examine the domain interactions involved in the homotypic bind- ing of the BGPc molecule and to epitope map the CD66 monoclonal antibodies (MoAbs).
MATERIALS AND METHODS

Cells and Cell Lines
Human peripheral blood neutrophils were obtained as described by Watt et alZh using a discontinuous gradient of Ficoll-hypaque with densities of 1.077 and 1.1 14 glmL and the neutrophils collected from the 1.1 14 glmL interface. The Chinese hamster ovary (CHO) cell transfectants were grown in HAMS-F10 medium (GIBCO, Paisley, UK) with 10% (vollvol) fetal calf serum (FCS). Cos 7 cells were grown in Dulbecco's minimum essential medium (DMEM; GIBCO) with 10% FCS (vollvol). Single-cell suspensions were obtained by trypsinisation with 0.15% (wtlvol) trypsin.
MOA bs
The rat MoAbs, YTH7I .3.2 (clustered as CD66) and YPC2ll2. I . were produced as described by Watt et al.'6 3BI0, AN312. MD1 1, and EA4, all mouse MoAbs that react with the CEA family," were kindly provided by Drs F. Wrba and H. Durbin (Imperial Cancer Research Fund, London, UK). CD3 and HPCA-2 (CD34) antibodies were obtained from Becton Dickinson (San Jose. CA). The rabbit antihuman CEA antibodies were obtained from Dakopatts (Copenhagen, Denmark). MoAbs to human CEA were also purchased from Dakopatts, Oxoid (Bassingstoke, Hamps., UK), and Seralab (Craw- 
Production of Soluble Recombinant Proteins
The plG vector. Details of the plG vector containing the Fc genomic fragment of human lgGl and incorporating the hinge (H), CH2, and CH3 domains are provided by Simmons" and by Watt et al." In brief, the lgGl gene segment was amplified from 250 ng of human genomic DNA from K562 cells by the PCR using 5' and 3' oligonucleotide primers (i) and (ii) (see Table I ).
The PCR product was digested with HindIIIlNot 1. cloned into Bluescript (Bluescript 11 SK). and sequenced on the forward strand only using sequence-specific primers at 200-bp intervals. No differences from the Genbank sequence were seen. The single BamHI site in the pCDM8 vector was removed by mung bean nuclease digestion and religation. The Fc genomic fragment was moved as a HindllIlNot I fragment from Bluescript and ligated into HindlIllNot I-digested RnmHI-minus pCDM8, bringing in the additional cloning sites, HindIII-EcoRV-EcoRI-Pst I-Smn I-BamHI, at the 5' extracellular domain (ECD) cloning site.
Soluble BGPc constructs. cDNA sequences encoding the whole ECDs of the BGPc and CD337".".2' were amplified by PCR using 94°C for I O minutes, followed by 4 cycles of 94°C for 0.5 minutes. 55°C for 1.5 minutes, and 72°C for 1 minute: and 24 cycles of amplification at 94°C for 0.5 minutes. 55°C for 0.5 minutes, and 72°C for 1 minute, both with Taq polymerase. The primers complementary to the 5' and 3' sequences of the T H M~ vector (iii) and the different domain boundaries of the coding regions of the ECD of BGPc (iv through vi), designed using information supplied by Dr P. Bates.74 and CD33 (vii), which were designed to include restriction enzyme sites, are listed in Table 1 .
For the production of BGPc-Fc domain constructs, PCR products of BGPc (N). (NAIBI), and (NAIBIA2) ECDs and the PIG construct were digested with Hind111 and EcoRI and ligated together as indicated previously.7" The BGPc (NAI B 1 A2). BGPc (NA I B I ). and BGPc (N) sequences were determined using primers 200 bp apart. The former two PCR products were identical to the appropriate sequences of the cloned BGPc ECD, whereas the BGPc(N) sequence showed identity for the first 430 bp of the total 435-bp ECD sequence used.'" The CD33 ECD PCR product and the PIG vector were digested with HindlIllBgl ll and HindIlIlBamHI, respectively. The digests were purified on 0.8% (wt/vol) agarose gels before ligation with T4 ligase. Because splice donor sites were just upstream of the 3' enzyme site, the ECD sequences of the BGPc domains and CD33 were then spliced in frame into the IgGl hinge with the resulting chimeric molecules dimerizing via this hinge. Plasmid preparations of the BGPc-Fc domain constructs and the CD33 construct were purified on CsCl gradient^.'^*'* The soluble molecules were transfected into Cos 7 cells using diethylaminoethyl (DEAE)-Dext r a n , ) ' and 3 to 7 days later the secreted proteins were collected and purified on protein A Sepharose (Pharmacia) as des~ribed.'~~"~'~ All samples, either unlabeled or metabolically labeled with ?%methio-nine,"' were subsequently analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 7.5% (wt/vol) gels under reducing and nonreducing condition^.'^
Quantitative Binding of Soluble Domain Constructs to CHO-BGPc Transfectants
For adhesion assays using the different domain constructs, 25-well nontissue culture plates (Sterilin, Stone, Staff, UK) were incubated with 10% (wtrvol) toluene in ethanol for 2 hours at room temperature, washed three times with ethanol, coated with rabbit antihuman Ig (1:3,000 dilution; Sigma Chemical CO, Poole, Dorset, UK) overnight at 4"C, washed three times in phosphate-buffered saline (PBS), incubated with 50 &.well of each soluble Fc domain construct overnight at 4"C, washed three times with PBS, and then blocked with 2% (wt/vol) bovine serum albumin (BSA) for 2 hours at room temperature. CHO-BGPc transfectants were trypsinized; resuspended in Ham's F10 medium with 10% (voVvol) FCS, 10 mmoU L thymidine, and 1 mCi/mL 'H-thymidine; and replated into new flasks overnight at 37°C for 24 hours before the adhesion assay. Cells were then trypsinized, washed, and resuspended in Puck's saline (GIBCO) containing 1 mmoUL CaC12 plus 1 mmoVL MgCl2 (pH 7.4) and 5% (wt/vol) dialyzed FCS at a concentration of 1 X lo6 cells/mL. Cells (5 X lo5) were added to each well for 1 hour at 37°C. The plate was washed twice with the same medium and the adherent cells were solubilized with 1% (wt/vol) SDS and counted in a p counter with 4 mL of ecoscint scintillant. For the cation dependency adhesion assays, the 'H-thymidine-labeled cells were first resuspended in Puck's saline containing 5 mmoVL EDTA (pH 7) and 5% (voUvol) FCS (dialyzed against PBS), washed three times in this medium, and then resuspended in either the same medium or Puck's saline plus 5% (voVv01) FCS containing 1 mmol/L CaCl,, 1 mmoVL MgC12, or 1 mmoUL of both cations.
For the time-course experiments, 96-well enzyme-linked immunosorbent assay (ELISA) plates (Costar, Cambridge, MA) were coated with rabbit antihuman Ig (1:3,ooO dilution; Sigma) overnight at 4°C and washed three times in PBS. Triplicate wells were incubated with 10 pg of BGPc-Fc-soluble construct overnight at 4"C, washed three times in PBS, and blocked with 2% (wt/vol) BSA solution for 2 hours at room temperature or overnight at 4°C. 'H-thymidine-labeled cells (lo5) in Puck's saline containing 1% (voUvo1) dialyzed FCS plus 1 mmoVL CaC12 and 1 mmol/L MgClz were added to each well for 1 hour at 37°C. The plate was washed twice with the same medium and the adherent cells were solubilized with 1% (wtrvol) SDS added to 3 mL of ecoscint scintillant and counted in a p counter.
Antibody Binding to Soluble BGPc Constructs
Ninety-six-well microtiter plates (Costar) were coated with the soluble constructs at a concentration of 200 pg/mL in PBS containing 1% (wt/vol) BSA at 4°C overnight. The plates were washed five times with PBS and incubated in PBS containing 3% (wtrvol) BSA for 2 hours at room temperature to block additional sites. After washing three times in PBS, the plate was incubated with antibodies (1:2 to 1:1,OOO dilutions) for 1 hour at room temperature, before the addition of biotinylated rabbit antimouse or antirat Ig (1 500 dilution) in PBS containing 1% (wt/vol) BSA for 1 hour at room temperature. The plates were washed three times with PBS, incubated with avidincoupled alkaline phosphatase (1:2,ooO dilution) for 1 hour at room temperature, and then washed three times in PBS. The substrate containing 10 mg p-nitrophenyl phosphate (Sigma) in l 0 mL of diethanolamine buffer was then added for 30 minutes at room temperature and the reaction was read on an ELISA reader at 405 nm.36 (Table 2) . Additional antibodies to CEA-related molecules were also tested against both CHO-BGPc transfectants and purified peripheral blood neutrophils. As indicated in Table 2 , the 3B10, 192, MD1 1, and CEA (oxoid) MoAbs as well as the rabbit polyclonal anti-CEA antibody bound both to neutrophils and the BGPc transfectants.
RESULTS
CD66 MoAbs That Identify the N-Terminal
Binding of antibodies to different domains of BGPc. Soluble constructs carrying the different extracellular domains of BGP are valuable tools for producing an initial epitope map for CD66 and anti-CEA antibodies. These constructs were designed to carry the BGP (N), (NAlBl), and (NAlBlA2) domains linked to the Fc portion of human IgG1. These are shown in Fig 2A. Metabolic labeling of these chimeric BGPc-Fc molecules with "S-methionine after transfection of Cos 7 cells showed molecular weights of approximately 55, 85, and 105 kD for the N, NAlB1, and NAlBlA2 Fc BGP constructs, respectively (Fig 2B, lanes  A, B, and C, respectively) , under reducing conditions. Under nonreducing conditions, the soluble forms of BGPc-Fc exist as dimers (Fig 2B, lanes E, F, and G, respectively) , dimerizing via the hinge region on the Fc segment of the molecule.
Using these BGPc-Fc domain constructs combined with an ELISA assay, the CD66 MoAbs, YTH71.3.2 and CLBgran 10 (M38), were found to bind to all soluble constructs, including the N-terminal domain construct that lacks IgC2-set domains (Table 3) . Epitope mapping of antibodies to the CEA family showed that these could be divided into three groups: those that reacted with the N-terminal domain of the BGPc molecule, the CD66 MoAbs and the CEA (rabbit), CEA (oxoid), MD11, and M192 anti-CEA antibodies; a second group of three MoAbs, YPC2/12.1,3B10, and EA4, which require the constant region domains, AlB1, for binding; and a third group that do not react with the soluble domain constructs. The latter include CEA (Dako) and CEA (Seralab) MoAbs (Table 3) . None of the MoAbs tested was specific for the A2 domain, ie, the extracellular domain of BGPc that distinguishes it from all other splice variants (with the exception of BGPa).
Adhesion Properties of BGPc
The N-terminal domain of BGPc mediates adhesion to CHO-BGPc transfectanrs. CH0 cells transfected with BGPc and the soluble constructs carrying the different BGPc extracellular domains are ideal candidates for studying the role of the different extracellular domains in homotypic interactions. To assess which of the extracellular domains of BGPc was responsible for the homotypic adhesion properties, soluble constructs carrying either the N-terminal domain only or the N-terminal domain plus two or three IgC2-set domains were analyzed for binding to CHO-BGPc transfectants. Figure 3 shows that, at 37°C and in the presence of cations, all constructs tested adhered to CHO-BGPc transfectants. No binding of the soluble molecules to CHO-CD34 transfectants (Fig 3) nor to nontransfected CH0 cells (data not shown) was observed. The CD33-Fc protein was used as a negative internal control for the specificity of the CHOBGPc adhesion (Fig 3) and was found to be negative. Human fibronectin (FN) served as a positive internal control for C H 0 cell binding (Fig 3) . Our results indicate that, because the BGP(N)-Fc construct alone was able to adhere to the CHO-BGPc cells, then this domain of BGP is responsible for the homotypic adhesion properties of this molecule.
Temperature dependency of adhesion. Rojas et a l l 3 have reported cation and temperature dependency for cell aggregation mediated by the BGPa isoform. To find out whether the same conditions are necessary for the homotypic adhesion shown by the BGPc-soluble isoform, a series of adhesion assays was performed at 4°C. No binding of the CHO-BGPc or CHO-CD34 transfectants to any of the different BGPc domain constructs was observed ( d a t a not shown). Physiologic temperatures were necessary for the adhesion process (Fig 3) .
Time course. To ascertain the optimal time required for adhesion of the CHO-BGPc transfectants to the BGPc (NA 1 B 1 A2)-Fc molecule, a time-course experiment was performed. Figure 4 shows that optimal binding of the CHOBGPc cells to the BGPc(NAlBlA2)-Fc molecule was achieved by 1 hour of incubation at 37°C. The adhesion capacity of the CHO-BGPc cells to the soluble molecules seemed to diminish by 3 hours of incubation.
Cation dependency. Cation dependency of BGPa-mediated adhesion has been a subject of controversy, with both Ca2+-dependentI3 and Ca2+-independent'6 adhesion being reported by two independent groups. Using our adhesion model, we were able to show that treatment of the CHOBGPc transfectants with 5 mmolL EDTA greatly inhibited their capacity for adhesion to the soluble BGP constructs (compare Fig 5B with A) . The addition of 1 mmol/L CaC12 to cells previously treated with EDTA partially restored the adhesion capacity of the CHO-BGPc transfectants, whereas the addition of 1 mmolL MgCIZ was able to fully restore their adhesion capacity (Fig 6) . The addition of both cations had the same effect as the addition of MgC12 only, with no synergistic effects being observed (Fig 6) .
DISCUSSION
The CD66 MoAbs, which included the majority of anti-CEA antibodies used in this report (but not the CD66b MoAbs), react with BGPc. This confirms that CD66 identi- 5 kD), BSA (69 kD), ovalbumin (46 kD),  carbonic anhydrase (30 kD), and lysozyme (14.3 kD) .
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fies at least four CEA family members, ie, BGP, NCA-50/90, NCA-95 (also known as CGM6). and CEA it~elf,'~.'~".."'.'~~'~ and provides additional evidence that CD66b MoAbs are specific for NCA-95."." Because BGPc consists of an Nterminal domain together with A I , B I , and A2 ECDs, different recombinant BGPc domain variants were used to construct an epitope map with the MoAbs described in this report. Most of the antibodies mapped to the N-terminal domain of BGPc, which shares 80% at the amino acid level with the N-terminal domain of the CEA and suggests that this domain is the most antigenic. None of the MoAbs tested reacted exclusively with the A2 domain. This domain distinguishes BGPa and BGPc from other BGP proteins and is only 45% homologo~s~.~ with the other IgC2-set domains within the CEA subgroup. Because antibodies mapping to this domain will in future prove essential for biologic and structural studies on these BGP splice variants, our domain constructs provide excellent and specific reagents for both antibody production and screening.
The functional significance of the different splice variants will depend on the cells and tissues in which they are expressed. RT-PCR analyses show that BGPc can be detected in both myeloid and colonic epithelial cells and cell although RNAse protection assays indicate that it is much more abundantly expressed in the colonic cell lines.' Homotypic adhesion has been shown to be mediaied by the BGPa and BGPb, and now by BGPc molecules.'~'."" By using different BGPc domain constructs, we have been able to show that homotypic adhesion of BGPc to the CHO-BGPc-transfected cells requires the N-terminal domain of BGPc. The absence of the other extracellular domains and of the cytoplasmic tail apparently does not affect the initial adhesion events. Further studies are required to show whether the adhesion described here involves N-N domain interactions only or whether other IgC2-set domains modify this adhesion or provide additional homotypic or heterotypic adhesion functions to these splice variants. The recent discovery by Bamett et al' that the A2 domain can be replaced with one of the two newly detected extracellular domains (Y and Z) by a process of differential splicing suggests important and diverse in vivo functions for the BGP family. Other proteins such as the N-CAM" and the human FGFR4' have been shown to possess several isoforms arising from differential splicing of their ECD exons. These splice variants exhibit different binding affinitie~.'''.~' It is likely that the generation of such diversity will also be functionally relevant in vivo for the BGP proteins. Time-course experiments using the full-length BGPc (NAIB IA2)-Fc proteins show that adhesion persists for 2 to 3 hours. Previous experiments by Rojas et all3 have indicated that BGPb transfectants (lacking the A2 domain), but not BGPa transfectants (possessing the A2 domain), show diminished aggregation by 2 hours of incubation. These results, taken together with our observations, suggest that the presence of the A2 domain in BGPa and BGPc may generate subtle differences in ligand interactions from other BGP splice variants, perhaps by strengthening or prolonging the adhesion process.
It is generally assumed that members of the Ig superfamily of adhesion molecules are cation-and temperature-indepen- the lattcr case, cations depleted with EGTA (which is a better chelating agent for Ca" than for Mg") did not alter BGPadependent cell aggregation. This suggests that either Ca'-is not required in their system or that Mg" is mediating these effects. The lymphocyte function-associated antigen-1 (LFA-I ) integrin"'.45 is one molecule that requires Mg?' for the highaffinity binding to the intercellular adhesion molecule-l (ICAM-I). This cation appears to be essential for inducing high-affinity conformational changes in integrin."
with the "outside-in" signals necessary for their adhesion functions. Temperature dependency implies that a metabolic process is necessary for adhesion rather then a simple intermolecular interaction that can take place at 4°C. This metabolic process may be related to cation uptake or release by the cells. conformational changes in the BGP molecule leading to different activation states, dimerization of BGP. the association of BGP with another unidentified ligand that promotes the adhesion process. or signal transduction. The BGPs are the only members of the CEA family that have been shown to exhibit temperature and cation-dependent adhesion, thus behaving more like cadherins. The cadherin family'" hinds cells by means of homotypic inter- 
